Shares of CVS Health Co. (NYSE:CVS – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-one ratings firms that are covering the stock, Marketbeat reports. Three ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...

Discover top "safer" F500IL stocks like Energy Transfer & AT&T with dividends surpassing share prices. Click for my top ...

This week has shown the stock’s resilience—the shares have jumped in the past two sessions both with and without the support of broader tech rebound.

Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, ...

Palantir (NASDAQ:PLTR) has built its success on the traction its AIP (artificial intelligence platform) has gained, and its commercial momentum ...

Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical ...

With a market cap of $30.2 billion, Louisville, Kentucky-based Humana Inc. (HUM) is a leading health care plan provider in ...

For retailers and marketers alike, Walgreens is a cautionary tale, but also a playbook on how brands must evolve to survive.

CVS is continuing the overhaul of its nationwide network, closing more locations this year and opening new, smaller stores ...